Curated basketTrending

Pharma Majors

Large-cap formulators, API makers and CDMO names — a curated basket, distinct from the exhaustive Pharma & Healthcare bucket.

13 companies
₹18.91L cr combined market capAs of 17 Nov 2026

This is an editorial list, not an index. No thematic index exists for us to source membership from, so the companies below were chosen by hand — treat the basket as a starting point for research rather than a definitive universe.

Returns

Cap-weighted with a 12% ceiling per company
Basis1D1W1M3M6M1Y
Cap-weighted-1.3%-2.4%+9.3%+7.7%+16.9%+30.1%
Equal-weighted-1.1%-2.5%+8.7%+5.9%+12.8%+25.5%
vs universe——+2.9pp+6.1pp+7.5pp—

Cap- and equal-weighted diverge. 6M +4.2pp, 1Y +4.6pp. The large members are carrying this theme — the typical company in it did less well than the headline suggests.

Why this label

Classified Trending because it was ahead of the universe over both 3 months and 1 month, with at least 55% of eligible members above their 200-day average. Relative strength is measured against DocStoX universe (5,481 companies).

1M vs universe
+2.9pp
3M vs universe
+6.1pp
6M vs universe
+7.5pp
Above 200-DMA
77%
Above 50-DMA
69%
Acceleration
-3.2pp

These are the exact figures the nightly classifier read — not a recalculation in your browser. A dash means the input could not be computed, in which case no label is assigned at all.

Breadth

13 of 13 eligible
Above 200-day average77%
Above 50-day average69%
Median RSI
56.4
Oversold
0
RSI below 30
Overbought
1
RSI above 70

These percentages are of the 13 members that carry moving-average history, not all 13. Members without enough price history are excluded from both the numerator and the denominator.

Valuation

Medians, not averages — one loss-making outlier cannot drag the whole theme.

Median P/E
36.9
from 13 companies
Median ROE
13.7%
from 13 companies

Each median names the number of companies behind it. Companies without a reported figure are excluded from that median rather than counted as zero.

Leaders & laggards

All 13 companies

A dash means we have no figure — not a zero
Companies in the Pharma Majors theme, with weight, market cap, price, returns and valuation.
DIVI S LABORATORIES LTDDIVISLAB+21.9%
SUN PHARMACEUTICAL IND LSUNPHARMA+6.3%
TORRENT PHARMACEUTICALS LTORNTPHARM+2.4%
LAURUS LABS LIMITEDLAURUSLABS+13.5%
ZYDUS LIFESCIENCES LTDZYDUSLIFE+7.2%
DR. REDDY S LABORATORIESDRREDDY+12.6%
CIPLA LTDCIPLA+4.7%
MANKIND PHARMA LIMITEDMANKIND+14.7%
AUROBINDO PHARMA LTDAUROPHARMA+7.6%
LUPIN LIMITEDLUPIN-0.6%
GLENMARK PHARMACEUTICALSGLENMARK+17.5%
ALKEM LABORATORIES LTD.ALKEM+2.5%
BIOCON LIMITED.BIOCON+2.9%

Pharma Majors stocks — frequently asked

How many Pharma Majors stocks are listed in India?
DocStoX tracks 13 listed Pharma Majors companies across NSE and BSE, selected as a curated basket rather than from an index.
How have Pharma Majors stocks performed over the last 3 months?
The Pharma Majors theme returned +7.7% over three months on a market-cap-weighted basis (each company capped at 12%), measured against DocStoX universe (5,481 companies).
Are Pharma Majors stocks trending?
DocStoX currently labels this theme "Trending", based on its 1-month and 3-month relative strength and the share of members above their 200-day and 50-day moving averages. This is a data classification, not investment advice.
Which Pharma Majors stock has performed best recently?
DIVI S LABORATORIES LTD (DIVISLAB) leads the theme over the last month at +21.9%. Past performance does not indicate future returns.

Other curated baskets

Compare this theme with the rest of the market.

All themes

Themes are informational groupings of listed companies, not recommendations, portfolios or indices. Figures are computed nightly from end-of-day data and may lag the live market. This is not investment advice — consult a SEBI-registered adviser before investing.